HCA
DGX icon

Harbour Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Harbour Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-570
Closed -$56K – 325
2017
Q1 		$56K Buy
+570
New +$54.3K 0.03% 370

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harbour Capital Advisors's DGX Position: Q2 2017 in Review

Harbour Capital Advisors sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 570 shares — an estimated $56K sold.

Harbour Capital Advisors first reported a position in DGX in Q1 2017 and held it in 1 quarter. The position peaked at $56K in Q1 2017. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Harbour Capital Advisors reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Harbour Capital Advisors sold 570 Quest Diagnostics shares in Q2 2017, an estimated $56K.
  • Harbour Capital Advisors first reported a position in Quest Diagnostics in Q1 2017 and held it in 1 quarter.
  • Harbour Capital Advisors's Quest Diagnostics position peaked at $56K in Q1 2017.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Harbour Capital Advisors's 13F filing for Q2 2017, filed 27 Jul 2017.